Malignant Head and Neck Neoplasm — Trials

Malignant Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,452 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,433
Recruiting: 781
Ph III recruiting: 109
Growth YoY: +20.1%
Industry share: 18%
Top sponsor: Sun Yat-sen University
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (629)

clinicaltrialsPublishedShowing 601–650 of 1,978 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05169437	Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors(PAVO)	terminated	Phase 2	22	Tempus AIINDUSTRY	1	Oct 29, 2025	clinicaltrials
NCT02882282	Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia	completed	Phase 2	15	M.D. Anderson Cancer CenterOTHER	1	Oct 23, 2025	clinicaltrials